Cellular response to oncogenic Ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)

Molecular and Cellular Biology

Volumn 20, Issue 8, 2000, Pages 2915-2925

  Malumbres, Marcos ^a,b   Pérez De Castro, Ignacio ^a   Hernández, María I ^a   Jiménez, María ^a   Corral, Teresa ^a   Pellicer, Angel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Invest Oncol Carlos III Ctr Nac   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P15; PROTEIN P16;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA METHYLATION; FIBROBLAST; FLOW CYTOMETRY; GENE ACTIVATION; GENE DELETION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SENESCENCE;

3T3 CELLS; ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MICE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0343293944     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.8.2915-2925.2000     Document Type: Article

References (82)

1. Albright, C. F., B. W. Giddings, J. Liu, M. Vito, and R. A. Weinberg. 1993. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J. 12:339-347.
2. Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barret. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
3. Altschmied, J., and J. Duschl. 1997. Set of optimized luciferase reporter gene plasmids compatible with widely used CAT vectors. BioTechniques 23: 436-438.
4. Batova, A., M. B. Diccianni, J. C. Yu, T. Nobori, M. P. Link, J. Pullen, and A. L. Yu. 1997. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 57: 832-836.
5. Campbell, S. L., R. Khosravi-Far, K. L. Rossman, G. J. Clark, and C. J. Der. 1998. Increasing complexity of Ras signaling. Oncogene 17:1395-1413.
6. Chin, L., J. Pomerantz, D. Polsky, M. Jacobson, C. Cohen, C. Cordon-Cardo, J. W. Horner 2nd, and R. A. DePinho. 1997. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11:2822-2834.
7. Chin, L., J. Pomerantz, and R. A, DePinho. 1998. The INK4a/ARF tumor suppressor: one gene - two products - two pathways. Trends Biochem. Sci. 23:291-296.
8. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
9. D'Adamo, D. R., S. Novick, J. M. Kahn, P. Leonardi, and A. Pellicer. 1997. rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral. Oncogene 14:1295-1305.
10. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke, and J. Campisi. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
11. Downward, J. 1997. Routine role for Ras. Curr. Biol. 7:R258-R260.
12. Erickson, S., O. Sangfelt, M. Heyman, J. Castro, S. Einhorn, and D. Grandér. 1998. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene 17:595-602.
13. ARF. Cell 91:555-558.
14. INK4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261.
15. Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, et al. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91: 7415-7419.
16. Hartsough, M. T., R. S. Frey, P. A. Zipfel, A. Buard, S. J. Cook, F. McCormick, and K. M. Mulder. 1996. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J. Biol. Chem. 271: 22368-22375.
17. Herman, J. G., J. Jen, A. Merlo, and S. B. Baylin. 1996. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56:722-727.
18. Herman, J. G., C. I. Civin, J. P. Issa, M. I. Collector, S. J. Sharkis, and S. B. Baylin. 1997. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57: 837-841.
19. Hitomi, M., and D. W. Stacey. 1999. Cellular Ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells. Mol. Cell. Biol. 19:4623-4632.
20. INK4a and the control of cellular proliferative life span. Carcinogenesis 20:921-926.
21. Jeffers, M., and A. Pellicer. 1994. Identification of multiple promoters within the N-ras proto-oncogene. Biochim. Biophys. Acta 1219:623-635.
22. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day 3rd, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
23. ARF. Cell 91:649-659.
24. Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:75-79.
25. Kerkhoff, E., and U. R. Rapp. 1997. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17:2576-2586.
26. Kerkhoff, E., and U. R. Rapp. 1998. High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res. 58:1636-1640.
27. Land, J., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
28. INK4B through an Sp1 consensus site. J. Biol. Chem. 270:26750-26753.
29. Li, Y., M. A. Nichols, J. W. Shay, and Y. Xiong. 1994. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54:6078-6082.
30. Lin, A. W., M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12: 3008-3019.
31. INK4b in undifferentiated mouse skin tumors. Cancer Res. 55:5168-5172.
32. Lloyd, A. C. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev. 8:43-48.
33. Lloyd, A. C., F. Obermuller, S. Staddon, C. F. Barth, M. McMahon, and H. Land. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11:663-677.
34. Lois, A. F., L. T. Cooper, Y. Geng, T. Nobori, and D. Carson. 1995. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res. 55:4010-4013.
35. Malumbres, M., and A. Pellicer. 1998. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3:887-912.
36. INK4a alterations in murine primary T-cell lymphomas. Oncogene 14:1361-1370.
37. Malumbres, M., R. Mangues, N. Ferrer, S. Lu, and A. Pellicer. 1997. Isolation of high molecular weight DNA for reliable genotyping of transgenic mice. BioTechniques 22:1114-1119.
38. INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene 18:385-396.
39. Matesanz, F., and A. Pellicer. 1995. In vivo and in vitro analysis of retroviral vectors carrying the N-ras oncogene. Int. J. Oncol. 7:443-451.
40. McConnell, B. B., M. Starborg, S. Brookes, and G. Peters. 1998. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8:351-354.
41. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:686-692.
42. Waf1 in NIH3T3 cells. Oncogene 12:775-784.
43. Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto. 1996. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:3065-3075.
44. Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirements for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313:241-243.
45. Mulder, K. M., and S. L. Morris. 1992. Activation of p21 ras by transforming growth factor beta in epithelial cells. J. Biol. Chem. 267:5029-5031.
46. Waf1/Cip1. Nature 394: 295-299.
47. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 15:495-503.
48. Palmero, I., C. Pantoja, and M. Serrano. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125-126.
49. Peters, G. 1994. Stifled by inhibitors. Nature 371:204-205.
50. Pollock, P. M., J. V. Pearson, and N. K. Hayward. 1996. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 15:77-88.
51. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8: 9-22.
52. Pumiglia, K. M., and S. J. Decker. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94:448-452.
53. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
54. INK4b genes. Oncogene 11: 635-645.
55. Reif, K., C. D. Nobles, G. Thomas, A. Hall, and D. A. Cantrell. 1996. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445-1455.
56. Robertson, K. D., and P. A. Jones. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18:6457-6473.
57. Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Rule of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
58. Ruas, M., and G. Peters. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378:F115-F177.
59. Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606.
60. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17:2458-2467.
61. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
62. Serrano, M., E. Gómez-Lahoz, R. A. DePinho, D. Beach, and D. Bar-Sagi. 1995. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science 267:249-252.
63. Serrano, M., H. W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37.
64. INK4a. Cell 88:593-602.
65. Cp1. Mol. Cell. Biol. 17: 5588-5597.
66. Sharpless, N. E., and R. A. DePinho. 1999. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9:22-30.
67. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
68. Stone, S., P. Dayananth, P. Jiang, J. M. Weaver-Feldhaus, S. V. Tavtigian, L. Cannon-Albright, and A. Kamb. 1995. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 11:987-991.
69. Swafford, D. S., S. K. Middleton, W. A. Palmisano, K. J. Nikula, J. Tesfaigzi, S. B. Baylin, J. G. Herman, and S. A. Belinsky. 1997. Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol. Cell. Biol. 17: 1366-1374.
70. Tan, T.-H., J. Wallis, and A. J. Levine. 1986. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J. Virol. 59:574-583.
71. Urano, T., R. Emkey, and L. A. Feig. 1996. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:810-816.
72. KIP2 requires binding to proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. USA 95:1392-1397.
73. Weinberg, R. A. 1997. The cat and mouse games that genes, viruses, and cells play. Cell 88:573-575.
74. Westwick, J. K., A. D. Cox, C. J. Der, M. H. Cobb, M. Hibi, M. Karin, and D. A. Brenner. 1994. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc. Natl. Acad. Sci. USA 91:6030-6034.
75. White, M. A., C. Nocolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533-541.
76. Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16: 6748-6761.
77. Cip1. Mol. Cell. Biol. 17:5598-5611.
78. Yue, J., A. Buard, and K. M. Mulder. 1998. Blockade of TGFbeta3 upregulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells. Oncogene 17:47-55.
79. Zhu, J., D. Woods, M. McMahon, and J. M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997-3007.
80. INK4b genes in 2′,3′-dideoxycytidine-and 1,3-butadiene-induced murine lymphomas. Oncogene 16:803-808.
81. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203-211.
82. Zindy, F., J. van Deursen, G. Grosveld, C. J. Sherr, and M. Roussel. 2000. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20:372-378.